Price
No data yet.
Social Signal Score
Revenue
$47.00-100.00%Company Profile
- CEO
- Joel Gagnier
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2
- Beta
- 2.78
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -4298.42
Financials
Revenue
$47.00-100.0%Net Income
$-8.2K-103.9%EBITDA
$-8.2K-102.5%Free Cash Flow
—EPS (diluted)
$0.00-100.0%Shares Outstanding (diluted)
780.43M+7944.3%Operating Expenses
$8.2KCash & Debt
$140.00Return of Capital
$0.00Dividend per Share
$0.01Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $0.00 | $-359.2K | $0.00 |
| 2023 | $72.00 | $-1.2K | $0.00 |
| 2022 | $92.1K | $-507.0K | $-0.00 |
| 2021 | $18.0K | $14.7K | $0.00 |
| 2020 | $73.9K | $-43.1K | $-0.00 |
| 2019 | $16.5K | $-34.8K | $-0.00 |
| 2018 | $22.3K | $-111.8K | $-0.00 |
| 2017 | $131.2K | $-17.5K | $-0.00 |
| 2016 | $0.00 | $-1.1K | $-0.00 |
| 2015 | $0.00 | $-96.0K | $-0.00 |
| 2009 | $5.11M | $-1.89M | $-0.20 |
| 2008 | $5.41M | $-2.23M | $-0.24 |
| 2007 | $4.50M | $-1.72M | $-0.17 |
| 2006 | $6.94M | $-2.29M | $-0.23 |
Valuation
FITYhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsaccessnewswire.com·7h ago·Negative
…, rehabilitation, connective tissue support, joint health, and peptide-focused research VANCOUVER, BC / ACCESS Newswire / August 26, 2026 / Fifty 1 Labs, Inc. (OTCID:FITY), an emerging biotechnology and health innovation company focused on peptide science, musculoskeletal health, sports performance, injury recovery, rehabilitation, and evidence-driven wellness, today announced that it has acquired a musculoskeletal recovery product line from MSK Signal, a Canadian Biotech Company. The acquired p…
View source ↗
Insider trading
Open-market buys and sells by FITY officers and directors.
- Bought
- $120k
- Sold
- —
9 trades
0 trades
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
- Severson Mark Abought
13 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.